Abbott Launches Digene Insta on the Go – Instant Relief from Acidity, Anytime, Anywhere
Abbott is redefining on-the-go wellness with the launch of Digene Insta On The Go—a ready-to-use antacid solution that delivers relief in just 2 seconds.
Business Wire India
Abbott is redefining on-the-go wellness with the launch of Digene Insta On The Go—a ready-to-use antacid solution that delivers relief in just 2 seconds. With Digene Insta On The Go, Abbott has introduced a ready-to-use, water-free solution that fits seamlessly into the fast-paced lives of today's consumers. It provides fast and effective relief from acidity, heartburn, and indigestion. 1 Developed for people with busy lifestyles, this fast-acting formula acts in just 2 seconds 2 —delivering convenience. Each 10 ml sachet is ready to use and effectively targets acidity and gas-related discomfort. It is designed for instant use, without the need for water, mixing, or measuring. Simply tear open the sachet and sip for direct relief. Digene Insta On The Go is now available in refreshing mint flavor at Rs.50 for a pack of five single-use sachets. Dr. Jejoe Karankumar, Director of Medical Affairs at Abbott, said, 'Acidity can strike without warning – during a hectic workday, while traveling, or even on your daily commutes 3,4 . This ready-to-use, handy solution delivers rapid relief within seconds and is effective for over two hours 1 . Backed by the trust of a legacy brand, it blends proven efficacy with unmatched convenience—all in a compact, pocket-friendly format designed for life on the move.'
The development of this new format was deeply rooted in consumer insights that revealed a growing demand for fast, discreet, and portable solutions to manage acidity. These insights guided Abbott to reimagine the delivery of relief, resulting in a water-free, single-use sachet that aligns with the spontaneous and mobile nature of modern lifestyles. By listening closely to consumer pain points and preferences, Abbott has created a solution that not only meets but anticipates the needs of today's fast-paced world.
To amplify the launch, Digene has rolled out a high-impact, integrated campaign: 'Acidity Kaheen Bhi Ho, Digene Insta On The Go' . This digital-first initiative spans outdoor activations, retail touchpoints, and online platforms—ensuring visibility where it matters most. The campaign includes engaging films such as the Multiplex Film , the Bus Film , and the Adventure Film . Digene Insta On The Go is a new addition to the Digene range, India's No.1 antacid brand 5 , offering consumers another option for managing acidity. Now available at major pharmacies and online platforms across India, Digene Insta On The Go complements Abbott's trusted range of antacid solutions, including Digene Gel and Tablets.
### Refers to the time taken to bring the pH to 3.5, after the amino acid comes in contact with gastric acid. Improved formula refers to higher strength formula with Higher ANC. An invitro study comparing the Preliminary Antacid Test, Acid Neutralizing Capacity and Acid Neutralizing Potential of two antacid products. URAR. Available at: https://www.ijrar.org/IJRAR24D1385.pdf . Dhawal PP, Barve SS. Preliminary in-vitro evaluation of marketed formulations for antacid activity. Int J Basic Clin Pharmacol. 2019:2319-003. Wisely, R. (2018) Why sleep disorders cause heartburn (and vice versa), Why Sleep Disorders Cause Heartburn (and Vice Versa). Available at: https://www.michiganmedicine.org/health-lab/why-sleep-disorders-cause-heartburn-and-vice-versa Heartburn: Causes, symptoms, and treatment (no date) WebMD. Available at: https://www.webmd.com/heartburn-gerd/understanding-heartburn-basics IQVIA Data April 2025
Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same.
Ahmedabad Plane Crash
Business Wire India, established in 2002, India's premier media distribution company ensures guaranteed media coverage through its network of 30+ cities and top news agencies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
a day ago
- Business Upturn
Cosmo First's Zigly acquires Dr. Santa Animal Healthcare, launches multi-speciality pet care centre in Whitefield, Bengaluru
By Aman Shukla Published on July 28, 2025, 16:36 IST Zigly, India's first tech-enabled omni-channel pet care brand and a part of Cosmo First, has announced the strategic acquisition of Dr. Santa Animal Healthcare, a reputed veterinary clinic based in Bengaluru. The acquisition marks the launch of Zigly's full-fledged 24×7 multi-speciality pet hospital in Whitefield, reinforcing its commitment to premium pet wellness services. The Whitefield centre will offer round-the-clock veterinary care, surgeries, diagnostics, grooming spa, and curated pet products from Applod, FurPro, and Zigly Lifestyle. Dr. Santa, with over five years of experience and Rs 2.23 crore (unaudited) in FY25 revenue, brings a strong client base and operational legacy. With this expansion, Zigly now operates six centres in Bengaluru—HSR Layout, JP Nagar, New Bel Road, Koramangala, Karthik Nagar, and Whitefield. The acquisition includes all assets, employees, and customer data, ensuring a seamless transition for existing pet parents. Pankaj Poddar, Group CEO of Cosmo First, said the move strengthens Zigly's mission to deliver holistic and modern pet care. The new centre is located at Pattandur Agrahara Village, Ambedkar Nagar, Whitefield. This launch further positions Zigly as a leader in India's growing premium pet care segment, offering tech-enabled, comprehensive wellness solutions for pets. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Dominion Post
3 days ago
- Dominion Post
Mon Medical Center participates in trial for device that could revolutionize Afib treatment
dbeard@ MORGANTOWN – Vandalia Health Mon Medical Center is participating in a clinical trial that could forever change how patients with atrial fibrillation are treated. The trial is called Catalyst, for the Abbott Medical Devices Amplatzer Amulet Left Atrial Appendage Occluder. The Amulet is already in use for Afib patients who can't use oral anticoagulants (blood thinners), said Dr. Wissam Gharib, who is leading the trial at Mon Medical. But this could broaden its use to all Afib patients, he said. This trial, he said, follows a similar trial, called Champion-AF, for the Watchman device by Boston Scientific. If the trials are successful, he said, 'This will be a paradigm shift in how we treat patients.' Abbott describes Afib as irregular electrical impulses in the upper chambers of the heart that cause those chambers to fibrillate, or quiver. This results in an irregular and frequently rapid heart rate that affects the heart's ability to pump blood, allowing blood to pool and collect in the left atrial appendage. Abbott explains that there is a muscular pouch connected to the left atrium of the heart called the left atrial appendage. If the blood clots are pumped from the appendage out into the body, the clots may flow to the brain and lead to stroke. The Amulet and the Watchman are both inserted via catheter to seal off the left atrial appendage. Gharib explains that patients diagnosed with Afib are first treated with blood thinners. For those who can't tolerate the medications, the Amulet and the Watchman provide an alternative approved by the FDA. The Catalyst and Champion trials, he said, aim to learn if the devices function as well as blood thinners and could be offered as an immediate alternative to blood thinners for everyone. Blood thinners, he said, carry various costs: among them are bleeding, clearances for dental work, pausing for surgical procedures, and the financial costs of being on the medications for life. If the trials prove the devices are as good as a blood thinner, a patient will have a choice. 'That's where these two trials are really pivotal in how we treat atrial fibrillation,' he said. The Champion trial – conducted at 141 locations, including Mon Medical – is complete and waiting on five-year results. Catalyst – being conducted at 132 locations, including Mon Medical – under way. Gharib said they have performed a number of procedures already and are still enrolling participants. He expects this portion of the trial will conclude at the end of the year. Volunteers are split into two groups: half get the Amulet, half get blood thinners. Participants have regular follow-up appointments for the five-year study period. Patients will know within a few weeks if the Amulet is working, he said, but the five-year period monitors long-term results and effects.
Los Angeles Times
4 days ago
- Los Angeles Times
Opinion: Looking into a lead-filled society
Although the majority of Orange County is filled with clean suburbs where good health and environment is expected, in the city of Santa Ana, there are many industrial regions where the air, water, and soil are polluted. These contaminants create an ugly landscape. More importantly, they pose substantial dangers to residents, who are a historically disproportionately marginalized community. According to the U.S. Environmental Protection Agency (EPA), if the amount of lead in the soil exceeds 400 parts per million (ppm) , it is deemed hazardous to health. The California Office of Environmental Health Hazard Assessment lowered the soil lead risk standard to just 80 ppm . However, in Santa Ana, out of the 1,500 soil samples collected, half of them were found to have exceeded the standard of 80 ppm. Furthermore, some samples were found to have reached an astounding 2,600 ppm, highlighting the severity of the issue. Interestingly, UCI-led research found that in the soil where the median household income was below $50,000, there was a 440% higher amount of lead than in places with a median household income of $100,000. Furthermore, over 50% of unsafe lead found in samples were primarily in places with more minority residents who cannot afford benefits such as health insurance. According to the samples collected, two main causes of the lead contamination issue in Santa Ana were found. The first was the excessive use of lead paint up to the year 1978. Buildings were primarily painted using lead paint, and their paint chips and dust continue to be a risk for lead poisoning. However, the main cause of the lead contamination was found to be from historical gasoline emissions. Santa Ana's many old highways and streets cause higher lead concentrations, especially due to its close proximity to neighborhoods. In fact, high levels of lead in children can cause many neurological issues such as developmental delay, learning difficulties, loss of appetite/weight loss, hearing loss, seizures, and more. Adults can also suffer from high blood pressure, joint/muscle pain, loss of memory and concentration, mood disorders, miscarriage, and other symptoms. Although there are still many challenges that the city of Santa Ana faces in regard to its lead contamination, there are many organizations working to make the city a safer place to live. Recently, an initiative headed by Jovenes Cultivando Cambios, called 'PloNo Santa Ana!' partnered with the Orange County Environmental Justice (OCEJ) organization to launch a General Plan (GP) to test lead, repair the soil, and to provide health care to residents who are impacted by the lead contamination. Furthermore, professors from UCI and community members of the Inequities in Childhood Life-Course Lead Exposure and Academic Neurobehavioral Outcomes (I-CLEAN) work to further study the impact that lead has on children. There are several things that all of us can do to alleviate this problem. For example, you can plant vegetation such as sunflowers, spinach, or corn, which have the ability to remove lead from the soil . Furthermore, such plants add much-needed greenspace to cities like Santa Ana. If you want to help advocate for larger changes, then you can join organizations such as the OCEJ PloNo! movement and help change environmental policies on both local and national levels. All of us can agree that everyone, especially children, deserve to live in clean environments. It is our collective responsibility to ensure that we build a country in which everyone has the right to live free of dangerous pollution and contaminants. Related
